|
Dr Ramani A Aiyer is Chief Scientific Officer, Actis Biologics Private Limited, Mumbai (INDIA), a start-up biotechnology company focused on discovery and development of innovative and novel bio-therapeutic products. Prior to that he was Senior Vice President, Strategic Planning, R&D at Nicholas Piramal India Limited, Mumbai, where his responsibilities included Business Development & Licensing and Project Management of new drug discovery and development programs. Prior to this he was Chief Operating Officer at Avesthagen, a start-up biotechnology company in Bangalore.Before moving to India, Dr Aiyer had over 17 years of experience in the biotechnology industry in the USA. He held senior positions in R&D and Business Development at biopharmaceutical companies including Genentech, LifeScan (subsidiary of Johnson & Johnson) and Sugen (subsidiary of Pharmacia/Pfizer). He received an MBA from University of California, Berkeley, has a PhD in Biochemistry from Harvard University, and did post-doctoral research at Stanford University. | 